# Evolocumab (Genetical Recombination) S.C. Injection 140mg Pen (レパーサ皮下注１４０ｍｇペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2189401G2026). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2189401G2026
- **Product name (Japanese):** レパーサ皮下注１４０ｍｇペン
- **English title:** Evolocumab (Genetical Recombination) S.C. Injection 140mg Pen
- **Active ingredient:** エボロクマブ（遺伝子組換え）
- **Active ingredient (INN):** Evolocumab (Genetical Recombination)
- **Strength / unit:** １４０ｍｇ１ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 21 Cardiovascular agents (循環器官用薬) › 218 Antihyperlipidemics (高脂血症用剤)
- **Manufacturer:** Amgen (アムジェン)
- **NHI price (reference only):** JPY 24302 per １４０ｍｇ１ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2189401G2026
- **JSON:** https://www.nifujipharma.com/api/drugs/2189401G2026

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Evolocumab%20(Genetical%20Recombination)%20S.C.%20Injection%20140mg%20Pen%20(%E3%83%AC%E3%83%91%E3%83%BC%E3%82%B5%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%94%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%9A%E3%83%B3)%20%2F%20YJ%202189401G2026#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.